Skip to main content

News

April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
October 14, 2018
Computed tomography-guided percutaneous microwave ablation is safe and well-tolerated in patients with renal cell carcinoma and achieves nephron preservation similar to existing ablative modalities.
October 14, 2018
A new study found that Y90 radioembolization with glass microspheres given at a boosted dose in patients with large hepatocellular carcinomas (HCCs) may show favorable tumor response.
October 03, 2018
Percutaneous image-guided core needle biopsies in tumor >2 cm are safe and effective in obtaining tumour genetic material, according to a study published in the European Journal of Cancer.
September 30, 2018
A new study that looked at outcomes of surgical resection after yttrium-90 (Y90) transarterial radioembolization (TARE) in patients with hepatocellular carcinoma found that TARE can serve as a safe bridge to resection.
September 23, 2018
Older age or a higher rate of comorbidities with age do not affect survival in metastatic colorectal cancer when patients receive radiofrequency ablation, high-dose-rate brachytherapy, or Y90-radioembolization, according to a study published in BMC…
September 18, 2018
The mutational status and histopathologic grade of patients with chemorefractory colorectal liver metastases (CRLM) may predict survival after Y90 radioembolization therapy, according to a study published in Oncotarget.
September 16, 2018
Using 3D voxel-based dosimetry in patients with hepatocellular carcinoma treated by yttrium-90 resin microspheres radioembolization, a new study determined that complete tumor targeting and 90Y dose to tumor are independent factors associated with…
September 09, 2018
According to a new study, 90Y transarterial radioembolization around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival and overall survival in patients with hepatic metastases from uveal…
September 05, 2018
In an exploratory case of a patient with metastatic colorectal cancer, a hotspot panel of cancer-associated gene mutations was used to identify tumor-specific mutations.
September 03, 2018
Tumor response can be predicted after 90Y radioembolization in patients with HCC by analyzing the delivered tumoral radiation dose by PET dosimetry.
Back to Top